Response to ‘Onabotulinum toxin injection in neurogenic detrusor overactivity: intradetrusor versus suburothelial’

Spinal Cord. 2013 Sep;51(9):726. doi: 10.1038/sc.2013.63.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Botulinum Toxins, Type A / administration & dosage*
  • Botulinum Toxins, Type A / therapeutic use*
  • Female
  • Humans
  • Male
  • Neuromuscular Agents / administration & dosage*
  • Neuromuscular Agents / therapeutic use*
  • Urinary Bladder, Neurogenic / drug therapy*

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A